| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6eed8d97257f0bde3d6ee2bedfa31e64 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2010-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93810f6e962dffe2e30b1dea07d0f0cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad020ab4284c840748f5a2cdd6da89f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15b6f34ec0b08b3e59ccdd000044415d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa4e025f4d7c124120225658f7380987
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe662ebae08661e51b46f5814aad668c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_729f6091c456b49c9805716a4e4be2f9 |
| publicationDate |
2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-347106-B |
| titleOfInvention |
PHARMACEUTICAL RELEASE OF IMMEDIATE RELEASE INCLUDING OXYCODONE AND NALOXONE. |
| abstract |
The present invention pertains to immediate-release oral pharmaceutical compositions suitable for treating patients suffering from pain, comprising oxycodone and naloxone or their salts and optionally a disintegrant as pharmaceutically acceptable excipients. |
| priorityDate |
2009-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |